14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for CRDF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.93 8.26 %
R2 3.84 5.74 %
R1 3.78 4.18 %
Current price: 3.63
Support S1 3.60 -0.87 %
S2 3.54 -2.43 %
S3 3.45 -4.96 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.04 11.29 %
R2 3.89 7.16 %
R1 3.65 0.551 %
Current price 3.63
Support S1 3.52 -3.03%
S2 3.49 -3.86%
S3 2.91 -19.83%

CRDF Predictions History

3 years ago
iHustle84 predicted that CRDF for 2020-09-28 is going $12.89 (5.83%)

3 years ago
JS predicted that CRDF for 2020-08-24 is going $7.29 (-5.32%)

3 years ago
sander7100 yo bro predicted that CRDF for 2020-08-21 is going $6.96 (-9.38%)

3 years ago
JS predicted that CRDF for 2020-08-21 is going $7.16 (-6.77%)

3 years ago
2poJeff predicted that CRDF for 2020-08-21 is going $6.92 (-0.14%)

Click to get the best stock tips daily for free!

About Cardiff Oncology Inc.

Cardiff Oncology. Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevac... CRDF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT